Given the new AHA Guidelines and the anticipation of new ESC Guidelines in 2019, what is your view about LDL-C level target thresholds vs. degree of LDL-C reduction? What level do you consider optimal in high-risk patients with progressive ASCVD?

Given the new AHA Guidelines and the anticipation of new ESC Guidelines in 2019, what is your view about LDL-C level target thresholds vs. degree of LDL-C reduction? What level do you consider optimal in high-risk patients with progressive ASCVD?

Get Credit

Given the new AHA Guidelines and the anticipation of new ESC Guidelines in 2019, what is your view about LDL-C level target thresholds vs. degree of LDL-C reduction? What level do you consider optimal in high-risk patients with progressive ASCVD?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical and Preventive Cardiologist's Perspective

Presenter

Dan Atar, MD

Dan Atar, MD

Head of Research Oslo University Hospital Ulleval Professor of Cardiology University of Oslo Oslo, Norway Visiting Associate Professorship Johns Hopkins University Baltimore, Maryland